Atlas Trials

Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

Clinical trial NCT01227135 · UNKNOWN

Trial details

NCT number
NCT01227135
Sponsor
Lynn McMahon
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2010-03-01
Primary completion
2012-03-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.